Paraneoplastic neurologic disorders and neurologic complications of immune checkpoint inhibitors.
1/5 보강
Paraneoplastic neurologic syndromes (PNS) are disorders resulting from an aberrant immune response against the nervous system, triggered by a tumor.
APA
Thakolwiboon S, Zekeridou A (2026). Paraneoplastic neurologic disorders and neurologic complications of immune checkpoint inhibitors.. Handbook of clinical neurology, 214, 85-103. https://doi.org/10.1016/B978-0-323-90887-0.00018-3
MLA
Thakolwiboon S, et al.. "Paraneoplastic neurologic disorders and neurologic complications of immune checkpoint inhibitors.." Handbook of clinical neurology, vol. 214, 2026, pp. 85-103.
PMID
41526153 ↗
Abstract 한글 요약
Paraneoplastic neurologic syndromes (PNS) are disorders resulting from an aberrant immune response against the nervous system, triggered by a tumor. Immune checkpoint inhibitor (ICI) cancer immunotherapies, enhance antitumor immunity by targeting immune checkpoint molecules on different cells, including immune and tumor cells. While ICIs improve cancer outcomes, these therapies can lead to immune-related adverse events (irAEs) in several systems including the nervous system. Neurologic irAEs may affect any level of the neuraxis, and, a subset of patients may present with syndromes resembling classic PNS. This chapter will discuss the epidemiology, pathogenesis, clinical manifestation, diagnostic approach, and treatment of PNS and neurologic irAEs.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.